Intas Pharmaceuticals Limited Ras Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Ras Export Records India — #2 Exporter, 731 Shipments, $36.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ras

India Pharmaceutical Trade Intelligence

$307.2M1,156 Suppliers176 CountriesHS 30049099

ExportsIndia → UNITED STATES29.3%India → SINGAPORE13.2%

#1 Supplier: CIPLA LIMITED

Intas Pharmaceuticals Limited — Ras Exporter #2 | $39.1M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Ras Exporter Profile

Indian Pharmaceutical Exporter · #2 for Ras · $39.1M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #2 Indian exporter of Ras with $39.1M in export value and 731 verified shipments. Intas Pharmaceuticals Limited holds a 11.9% market share in Ras exports across 28 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Ras Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Ras export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Ras?

Country	Value	Shipments	Share
UNITED KINGDOM	$12.1M	313	56.8%
CANADA	$3.7M	82	17.3%
PERU	$2.1M	47	10.0%
UNITED STATES	$930.1K	50	4.4%

Who Are the Top Buyers of Ras from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
FAWDON MANUFACTURING CENTRE ( SF )	UNITED KINGDOM	$4.1M	96
FAWDON MAUFACTURING CENTRE (SF)	UNITED KINGDOM	$3.1M	82
APOTEX - CANADA	CANADA	$2.4M	47
FAWDON MANUFACTURING CENTRE (SF)	UNITED KINGDOM	$1.9M	49
FAWDON MANUFACTURING CENTRE SF	UNITED KINGDOM	$1.3M	26
ACCORD HEALTHCARE S.A.C.	PERU	$1.1M	26
APOTEX CANADA	CANADA	$1.0M	20
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$929.8K	30
TO THE ORDER	POLAND	$873.8K	46
ACCORD HEALTHCARE S A C	PERU	$850.0K	17

Intas Pharmaceuticals Limited supplies Ras to 93 buyers globally. The largest buyer is FAWDON MANUFACTURING CENTRE ( SF ) (UNITED KINGDOM), followed by FAWDON MAUFACTURING CENTRE (SF) (UNITED KINGDOM) and APOTEX - CANADA (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ras Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI FILGRASTIM 300MCG/0.5ML PFS NUDE-EU TUB AS PER INVOICEVLS	$1.5M	36
PHARMACEUTICAL DRUGS AND MEDICINE-GRASTO	$1.1M	22
PHARMA DRUGS & MEDI: FILGRASTIM 480mcg/0	$709.6K	33
PHARMA DRUGS & MEDI: FILGRASTIM 300mcg/0	$683.6K	46
PHARMACEUTICAL DRUGS AND MEDICINE FILGRASTIM 300MCG/0.5ML PFS NUDE-EU TUB FILGRASTIM 300MCG/0.5ML PFS NUDE-EU TUB	$600.0K	12
PHARMA DRUGS & MEDI FILGRASTIM 300mcg/0.	$550.6K	12
PHARMA DRUGS & MEDI: PEGFILGRASTIM 6mg/0	$538.0K	18
PHARMA DRUGS & MEDI FILGRASTIM 300MCG/0.5ML PFS NUDE-EU TUB AS PER INVOICE	$537.0K	11
PH.DRU.& MED.: NEUGRAST INJECTION (FILGRASTIM INJECTION 300MCG/ML) [1X1 PFS]	$520.1K	11
PHARMA DRUGS & MEDI: PEG FILGRASTIM 6mg/	$495.2K	19

Intas Pharmaceuticals Limited exports 613 distinct Ras formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI FILGRASTIM 300MCG/0.5ML PFS NUDE-EU TUB with 36 shipments worth $1.5M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Ras Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	INTAS PHARMACEUTICALS LIMITED ★	$36.5M	731	28	$50.0K
4	MSN LABORATORIES PRIVATE LIMITED	$22.3M	512	24	$43.5K
3	MYLAN LABORATORIES LIMITED	$20.1M	402	16	$50.0K

Intas Pharmaceuticals Limited ranks #2 among 1156 Indian Ras exporters. Average shipment value of $50.0K compared to the market average of $106.8K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and MYLAN LABORATORIES LIMITED.

Which Indian Ports Ship Ras Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	1,417	9.4%
DELHI AIR CARGO ACC (INDEL4)	1,335	8.9%
NHAVA SHEVA SEA (INNSA1)	947	6.3%
SAHAR AIR	935	6.2%
DELHI AIR	709	4.7%
Bombay Air	648	4.3%
AHEMDABAD AIR ACC (INAMD4)	528	3.5%
TUTICORIN SEA (INTUT1)	406	2.7%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Ras Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ras shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 1,194 individual customs records matching Intas Pharmaceuticals Limited exporting Ras, covering 613 formulations to 42 countries via 93 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 176+ countries, 2,323+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ras

Ras

Intas Pharmaceuticals Limited — Ras Exporter Profile

Intas Pharmaceuticals Limited — Ras Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Ras?

Who Are the Top Buyers of Ras from Intas Pharmaceuticals Limited?

What Is India's Total Ras Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Ras Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Ras Exporters?

What Ras Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Ras to Key Markets

United Kingdom — MHRA

Canada — HC

How Does Intas Pharmaceuticals Limited Compare to Nearest Ras Exporters?

Which Indian Ports Ship Ras Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Ras Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ras Export Data from Intas Pharmaceuticals Limited

Ras Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source